The Communicate Study Partnership
Recruiting now · Phase 2
Conditions studied: Aboriginal Health, Cultural Safety, Access to Interpreters, Healthcare Provider Training
In brief
The vision of the Communicate Study Partnership is to ensure more Aboriginal patients receive culturally safe healthcare in their first language. The Communicate Study Partnership will implement and evaluate creative ways to embed cultural safety training and increase use of Aboriginal Interpreters and Aboriginal Health Practitioners at Northern Territory Top End hospitals. Quantitative outcomes (interpreter uptake, outcomes including leave against medical advice, costs) will be measured using time-series analysis. Qualitative outcomes derived from interviews with patient, healthcare provider and interpreter participants, will be informed by decolonising theory and participatory approaches. Successful project implementation will improve experience of care and health outcomes for Aboriginal people, build Aboriginal workforce, and improve healthcare provider satisfaction.
Key facts
- Study ID
- NCT05629416
- Run by
- Menzies School of Health Research
- People needed
- 340
- Starts
- 2022-05-23
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2023-02-16
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Different patient and provider participants (e.g. Aboriginal patients, Aboriginal interpreters, healthcare providers of any ethnicity) will be invited to participate in interviews, observations and surveys to assess effectiveness of study activities
You may not qualify if…
- None
Where it is running
- Royal Darwin Hospital — Darwin, Northern Territory, Australia (enrolling)
- Palmerston Hospital — Darwin, Northern Territory, Australia
- Katherine Hospital — Katherine, Northern Territory, Australia
- Gove District Hospital — Nhulunbuy, Northern Territory, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.